Kura Oncology (KURA) Current Leases (2019 - 2026)

Kura Oncology (KURA) has 8 years of Current Leases data on file, last reported at $1.3 million in Q1 2026.

• On a quarterly basis, Current Leases fell 32.65% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 32.65% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 32.11% from the prior year.
• Current Leases for Q1 2026 stood at $1.3 million, roughly flat from $1.3 million in the prior quarter.
• Over the last five years, Current Leases for KURA reached as high as $2.3 million in Q2 2023 and fell as low as $1.3 million in Q4 2025.
• Historically, Current Leases has averaged $1.8 million across 5 years, with a median of $1.7 million in 2025.
• Across the five-year window, Current Leases tumbled 41.55% in 2024 and surged 39.77% in 2025, its largest moves.
• Year by year, Current Leases stood at $2.3 million in 2022, then plunged by 35.03% to $1.5 million in 2023, then rose by 24.9% to $1.9 million in 2024, then slumped by 32.11% to $1.3 million in 2025, then rose by 0.47% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.